These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6772886)

  • 1. A review of the economic evidence on prevention.
    Scheffler RM; Paringer L
    Med Care; 1980 May; 18(5):473-84. PubMed ID: 6772886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reimbursement for preventive services: can we construct an equitable system?
    Davis K; Bialek R; Parkinson M; Smith J; Vellozzi C
    J Gen Intern Med; 1990; 5(5 Suppl):S93-8. PubMed ID: 2121920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economics of prevention.
    Russell LB
    Health Policy; 1984; 4(2):85-100. PubMed ID: 10310959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost--benefit concepts in health: examination of some prevention efforts.
    Lave JR; Lave LB
    Prev Med; 1978 Sep; 7(3):414-23. PubMed ID: 104290
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-benefit analysis of a prenatal preventive programme against congenital syphilis.
    Stray-Pedersen B
    NIPH Ann; 1980 May; 3(1):57-66. PubMed ID: 6779243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making the economic case for prevention--a view from Wales.
    Hale J; Phillips CJ; Jewell T
    BMC Public Health; 2012 Jun; 12():460. PubMed ID: 22716189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting cost-effectiveness analysis for preventive interventions: a guide for decision makers.
    Teutsch SM; Murray JF
    Am J Manag Care; 1999 Mar; 5(3):301-5. PubMed ID: 10351026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
    Goldstein JA; Winston FK; Kallan MJ; Branas CC; Schwartz JS
    Ambul Pediatr; 2008; 8(1):58-65. PubMed ID: 18191783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How much preventive care can we afford?
    Terry K
    Med Econ; 1993 Aug; 70(16):124-30, 132, 135-6. PubMed ID: 10127783
    [No Abstract]   [Full Text] [Related]  

  • 10. The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services.
    Saha S; Hoerger TJ; Pignone MP; Teutsch SM; Helfand M; Mandelblatt JS;
    Am J Prev Med; 2001 Apr; 20(3 Suppl):36-43. PubMed ID: 11306230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of out-of-pocket payments on prevention and health-related lifestyle: a systematic literature review.
    Rezayatmand R; Pavlova M; Groot W
    Eur J Public Health; 2013 Feb; 23(1):74-9. PubMed ID: 22544911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do we translate science into public health policy and law?
    Fielding JE; Marks JS; Myers BW; Nolan PA; Rawson RD; Toomey KE
    J Law Med Ethics; 2002; 30(3 Suppl):22-32. PubMed ID: 12508498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging diseases--do they prevent preventive health care from saving costs?
    Gandjour A
    Health Econ; 2009 Mar; 18(3):355-62. PubMed ID: 18833543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV.
    Mullins CD; Seal B; Seoane-Vazquez E; Sankaranarayanan J; Asche CV; Jayadevappa R; Lee WC; Romanus DK; Wang J; Hay JW; Smeeding J
    Value Health; 2010; 13(1):18-24. PubMed ID: 19807903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Critical Analysis of Obamacare: Affordable Care or Insurance for Many and Coverage for Few?
    Manchikanti L; Helm Ii S; Benyamin RM; Hirsch JA
    Pain Physician; 2017 Mar; 20(3):111-138. PubMed ID: 28339427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An economic appraisal of the benefits of screening for open spina bifida.
    Henderson JB
    Soc Sci Med; 1982; 16(5):545-60. PubMed ID: 6808668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health plan implementation of U.S. Preventive Services Task Force A and B recommendations--Colorado, 2010.
    Centers for Disease Control and Prevention
    MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(39):1348-50. PubMed ID: 21976117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the effectiveness of disease and injury prevention programs: costs and consequences.
    MMWR Recomm Rep; 1995 Aug; 44(RR-10):1-10. PubMed ID: 7565538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An economic framework for preventive care advice.
    Pauly MV; Sloan FA; Sullivan SD
    Health Aff (Millwood); 2014 Nov; 33(11):2034-40. PubMed ID: 25368000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.